Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
SCIGEN LIMITED (SIE)
ASX, Legal & CGT Status
Former (or subsequent) names
Shareholder links
REGISTRY:
Computershare, Level 5, 115 Grenfell Street, Adelaide SA 5000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 8 9473 2408 or 1300 534 987
RegistryWebsite RegistryEmail
Company details
Tel: 02-9485-1800 Fax: 02-9485-1888
Date first listed: 15/11/2002
Company Secretary:
Sector: Pharmaceuticals & Biotechnology
Industry Group: XHJ
Activities: Biopharmaceutical company that manufactures and delivers healthcare products globally - its focus is in the areas of endocrinology and immunology and its product portfolio includes vaccines and therapeutics
News & Events
delisted from the close of trading on Tuesday, 28 August 2018 pursuant to Listing rule 17.14. | 28/08/2018 |
we understand SAC Capital Private Limited was successful with an offer of US$0.0507 cash per Scigen share | 28/08/2018 |
the suspension of trading in the securities of SciGen Limited (the "Company") will be lifted on the commencement of trading on Friday, 3 April 2009, following receipt of the Company's Full Year Accounts for the period ended 31 December 2008, in accordance with listing rule 17.8 | 02/04/2009 |
shares suspended from quotation following failure to lodge full year accounts | 01/04/2009 |
with regard to the demerger in December 2002, Sonic shareholders received one SciGen share in the form of a CUFS for every Sonic share held - Sonic advised the Australian Taxation Office that SciGen represented 0.66% of the market value of the group as a whole just after the demerger - according to the Australian Tax Office shareholders who received SciGen shares should use this percentage to apportion the sum of the cost bases of their post-CGT Sonic shares between these shares and the post-CGT SciGen shares | 31/12/2002 |
ASX, Legal & CGT Status
ASX Announcements (courtesy of ASX)
Your comments
Company Updates
Post your comments here
Directors' on-market share transactions (last 5)
Directors & Executives (current)
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Slawomir Ziegert | Executive Chairman, CEO | 01/12/2009 |
| Marcin Dukaczewski | Non Exec Director | 26/12/2008 |
| Mateusz Kosecki | Non Exec Director | 01/12/2009 |
| Yvonne Lim | Executive Director | 08/09/2017 |
| Kang Yun | Director | 07/08/2018 |
| Zou Jun | Director | 07/08/2018 |
| Yanzhi Shi | Director | 08/08/2018 |
Date of first appointment, title may have changed.
Directors & Executives (former)
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Marek Dziki | Non Exec Chairman, CEO | 06/06/2016 | 31/08/2018 |
| Adam Polonek | Executive Director, CFO | 26/06/2008 | 31/08/2018 |
| Vaidyanathan Viswanath | Non Exec Director | 10/02/2017 | 07/08/2018 |
| Kenneth Gross | Non Exec Director | 03/07/2000 | 07/08/2018 |
| Ju bo Liu | Non Exec Director | 10/02/2017 | 07/08/2018 |
| Ashley Morris | Executive Director, CEO | 09/02/2017 | 08/09/2017 |
| Jenny Low | Executive Director, Administrator | 02/12/2009 | 30/06/2017 |
| James Kim | Executive Director | 18/04/2016 | 09/02/2017 |
| Adam Wilczega | Non Exec Director | 11/04/2005 | 01/04/2016 |
| Joanna Szymanska-Bulska | Non Exec Director | 26/06/2008 | 06/06/2014 |
| Amol Shah | Non Exec Director | 01/12/2009 | 25/04/2014 |
| Adam Aleksandrowicz | Executive Director, CFO | 03/03/2011 | 12/01/2012 |
Date of first appointment, title may have changed.